MGMT and glioma: In addition, it has been reported that O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, which has been regarded as the indicator of temozolomide (TMZ) chemotherapy resistance, is also more likely to occur in glioma female patients (14).